Sophie Giraud

6.4k total citations
71 papers, 2.4k citations indexed

About

Sophie Giraud is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sophie Giraud has authored 71 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Cancer Research and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sophie Giraud's work include Neuroendocrine Tumor Research Advances (17 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Neuroblastoma Research and Treatments (10 papers). Sophie Giraud is often cited by papers focused on Neuroendocrine Tumor Research Advances (17 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Neuroblastoma Research and Treatments (10 papers). Sophie Giraud collaborates with scholars based in France, Italy and United Kingdom. Sophie Giraud's co-authors include Richard J. Kahnoski, Alain Calender, Magnus Nordenskjöld, Eamonn R. Maher, Maurice A. M. Van Steensel, John Solly, Fred H. Menko, Lennart Friis‐Hansen, Thomas van Overeem Hansen and Silvana Ungari and has published in prestigious journals such as Blood, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Sophie Giraud

70 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophie Giraud France 28 984 889 508 458 446 71 2.4k
Irina A. Lubensky United States 26 815 0.8× 1.1k 1.2× 524 1.0× 652 1.4× 635 1.4× 41 2.2k
P N Plowman United Kingdom 28 773 0.8× 482 0.5× 493 1.0× 212 0.5× 726 1.6× 94 2.8k
Florence Coulet France 31 1.3k 1.4× 843 0.9× 217 0.4× 661 1.4× 743 1.7× 102 3.3k
Lindsay Middelton United States 17 845 0.9× 1.0k 1.2× 207 0.4× 419 0.9× 362 0.8× 27 1.8k
Ryma Benayed United States 33 2.1k 2.2× 1.0k 1.2× 296 0.6× 1.1k 2.4× 1.5k 3.4× 85 4.0k
Judith Dierlamm Germany 33 462 0.5× 1.0k 1.2× 143 0.3× 599 1.3× 1.3k 2.8× 111 4.1k
Ashish M. Ingle United States 24 673 0.7× 1.2k 1.4× 150 0.3× 348 0.8× 788 1.8× 36 2.5k
Adrián Mariño‐Enríquez United States 35 2.2k 2.3× 734 0.8× 290 0.6× 346 0.8× 861 1.9× 94 3.6k
Claudio Ghimenton Italy 24 624 0.6× 505 0.6× 224 0.4× 280 0.6× 302 0.7× 101 1.7k
Ian M. Frayling United Kingdom 31 414 0.4× 998 1.1× 208 0.4× 789 1.7× 1.4k 3.3× 72 3.3k

Countries citing papers authored by Sophie Giraud

Since Specialization
Citations

This map shows the geographic impact of Sophie Giraud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Giraud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Giraud more than expected).

Fields of papers citing papers by Sophie Giraud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Giraud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Giraud. The network helps show where Sophie Giraud may publish in the future.

Co-authorship network of co-authors of Sophie Giraud

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Giraud. A scholar is included among the top collaborators of Sophie Giraud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Giraud. Sophie Giraud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buffet, Alexandre, et al.. (2026). Insights from 2057 germline genetic tests in renal cell carcinoma patients support revisiting testing criteria. European Journal of Human Genetics. 34(3). 421–428.
2.
Lasolle, Hélène, Charles Dupin, J. Abeillon, et al.. (2025). Outcomes and Therapeutic Strategies for Head-and-neck Paragangliomas Associated With Succinate Dehydrogenase Mutations. The Journal of Clinical Endocrinology & Metabolism. 110(12). e4030–e4037. 1 indexed citations
3.
Saurin, Jean‐Christophe, Valérie Hervieu, Évelyne Decullier, et al.. (2024). Phenotypic characterisation of SMAD4 variant carriers. Journal of Medical Genetics. 61(8). 734–740. 2 indexed citations
4.
Giraud, Sophie, et al.. (2024). Prevalence of Hemoplasma spp. positivity in potential feline blood donors and study of the association with selected clinical variables. Journal of Veterinary Internal Medicine. 38(4). 2151–2157. 2 indexed citations
5.
Guilhem, A, Sophie Dupuis‐Girod, Olivier Espitia, et al.. (2023). Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated with EPHB4 pathogenic variants. Journal of Medical Genetics. 60(9). 905–909. 2 indexed citations
6.
Mohamed, Amira, Nelly Burnichon, Sophie Giraud, et al.. (2023). Update of the UMD-VHL database: classification of 164 challenging variants based on genotype–phenotype correlation among 605 entries. Journal of Medical Genetics. 61(4). 378–384. 2 indexed citations
7.
Giraud, Sophie, et al.. (2022). Construire un système alimentaire territorial durable. Norois. 262. 79–99. 4 indexed citations
8.
Péron, Julien, Alex Friedlaender, Valeria Viassolo, et al.. (2020). Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes. Scientific Reports. 10(1). 7073–7073. 72 indexed citations
9.
Friedlaender, Alex, Valeria Viassolo, Jean‐Damien Combes, et al.. (2018). BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients. Annals of Oncology. 29. viii76–viii76. 1 indexed citations
10.
Khoo, Joan, et al.. (2012). Novel Association of Thymic Carcinoid with a Germline Mutation in a Kindred with Multiple Endocrine Neoplasia 1 (MEN1). Experimental and Clinical Endocrinology & Diabetes. 120(5). 257–260. 2 indexed citations
11.
Peyre, Matthieu, Philippe David, R. Van Effenterre, et al.. (2010). Natural History of Supratentorial Hemangioblastomas in von Hippel-Lindau Disease. Neurosurgery. 67(3). 577–587. 34 indexed citations
12.
Duet, M., Charlotte Hautefort, Michel Wassef, et al.. (2010). Endolymphatic Sac Tumors in von Hippel-Lindau Disease. Otology & Neurotology. 31(4). 660–664. 7 indexed citations
13.
Hammel, Pascal, Olivier Corcos, Olivier LaRochelle, et al.. (2009). Pancreatic Endocrine Microadenomatosis in Patients With von Hippel-Lindau Disease. The American Journal of Surgical Pathology. 33(5). 739–748. 38 indexed citations
14.
Lesca, Gaëtan, Carla Olivieri, Nelly Burnichon, et al.. (2007). Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: Data from the French-Italian HHT network. Genetics in Medicine. 9(1). 14–22. 157 indexed citations
15.
Bessis, D., Sophie Giraud, & Richard J. Kahnoski. (2006). A novel familial germline mutation in the initiator codon of the BHD gene in a patient with Birt-Hogg-Dubé syndrome. British Journal of Dermatology. 155(5). 1067–1069. 24 indexed citations
16.
Navarro, Claudine, Eric Ruano, Françoise Desseigne, et al.. (2006). Systematic mRNA analysis for the effect ofMLH1 andMSH2 missense and silent mutations on aberrant splicing. Human Mutation. 27(2). 145–154. 68 indexed citations
17.
Bonadona, Valérie, P. Saltel, Françoise Desseigne, et al.. (2002). Cancer Patients Who Experienced Diagnostic Genetic Testing for Cancer Susceptibility. Cancer Epidemiology and Prevention Biomarkers. 11(1). 97–104. 1 indexed citations
18.
Teh, Bin Tean, Jan Zedenius, Soili Kytölä, et al.. (1998). Thymic Carcinoids in Multiple Endocrine Neoplasia Type 1. Annals of Surgery. 228(1). 99–105. 146 indexed citations
19.
Guichard, Sylvie M., et al.. (1996). [Clinical and genetic study of a familial case of multiple endocrine neoplasia type 1 (MEN 1). From value of multidisciplinary collaboration].. PubMed. 57(1). 64–70. 1 indexed citations
20.
Larsson, Catharina, Alain Calender, Sean M. Grimmond, et al.. (1995). Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1. Journal of Internal Medicine. 238(3). 239–244. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irina A. Lubensky Breakdown of academic impact, for papers by P N Plowman Breakdown of academic impact, for papers by Florence Coulet Breakdown of academic impact, for papers by Lindsay Middelton Breakdown of academic impact, for papers by Ryma Benayed Breakdown of academic impact, for papers by Judith Dierlamm Breakdown of academic impact, for papers by Ashish M. Ingle Breakdown of academic impact, for papers by Adrián Mariño‐Enríquez Breakdown of academic impact, for papers by Claudio Ghimenton Breakdown of academic impact, for papers by Ian M. Frayling
Rankless by CCL
2026